Novo Nordisk A/s
Patents = 1,772
Trademarks = 165
Forward Citations = 44,699
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
2,029 inventors (with patents filed for the assignee):
Novo Nordisk is a global healthcare company founded in Denmark in 1923. It specializes in the development, production, and distribution of pharmaceutical products and services. Novo Nordisk's main focus is on diabetes care, but it also offers treatments for rare bleeding disorders, growth hormone deficiencies, and obesity. With a strong commitment to scientific innovation and corporate sustainability, Novo Nordisk strives to improve the lives of patients worldwide.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com